Published in Immunotherapy Weekly, November 30th, 2005
According to recent research from Italy, "Helicobacter pylori is a microorganism able to stimulate a robust inflammatory and systemic immune response. The aim of our study was to evaluate autoimmune markers in dyspeptic patients positive for H. pylori infection compared to a control group of non-H. pylori-infected subjects."
"The kinetics of cryoglobulins and autoantibodies was evaluated after treatment of the infection. Dyspeptic patients with active H. pylori infection and age-and sex-matched healthy H. pylori-negative controls...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Immunotherapy Weekly